Published on 01/12/2025

Master Data Flows: GTIN, SN, GLN, SSCC, and Lots

In today’s increasingly regulated pharmaceutical environment, maintaining the integrity of master data flows is paramount for compliance and operational efficiency. This tutorial serves as a comprehensive guide for professionals involved in serialization, aggregation hierarchy, interface validation, and master data governance. Here, we will cover critical elements linked to master data flows such as Global Trade Item Number (GTIN), Serial Number (SN), Global Location Number (GLN), Serial Shipping Container Code (SSCC), and lots.

Understanding Master Data Flows in Pharmaceuticals

Master data flows are the backbone of effective serialization and aggregation processes in pharmaceutical supply chains. These flows encompass key identifiers that range from GTINs and SNs to GLNs and SSCCs. The movement and management of these data points are essential for complying with regulations such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU’s Falsified Medicines Directive (FMD).

Key Definitions:

• GTIN: A unique identifier for trade items, typically encoded in a barcode.
• SN: A unique code assigned to an individual item for tracking purposes.
• GLN: A unique identifier for locations, such as manufacturers, warehouses, and retailers.
• SSCC: A unique number used to identify logistics units for physical tracking.

Understanding these definitions will form the foundation of master data governance and will ease compliance with regulatory expectations in various regions including the US, UK, and EU. The importance of each identifier cannot be overstated when considering their role in serialization and aggregation.

Requirements Specification (URS) for Serialization

The User Requirements Specification (URS) is a critical document that outlines the needs and expectations of stakeholders involved in serialization and aggregation processes. Developing a comprehensive URS for serialization involves several key steps:

Step 1: Identify Stakeholders

Begin by identifying all relevant stakeholders, including:

• Quality Assurance (QA)
• Regulatory Affairs (RA)
• IT and Technical Support
• Operational Teams

Engage with these stakeholders to gather inputs that reflect their requirements related to serialization.

Step 2: Define Functional Requirements

In collaboration with your stakeholders, specify the functional requirements that the system must meet. These can include:

• The ability to generate and print GTINs and SNs
• Integration with existing enterprise systems
• Data capture and storage capabilities
• Exception handling procedures

Step 3: Regulatory Compliance Requirements

Your URS must consider compliance requirements across relevant jurisdictions. For example, the DSCSA establishes specific mandates around the use of serial numbers for tracking pharmaceuticals. Ensure that the URS includes checks for compliance with regulations such as EU FMD requirements as well.

Step 4: Review and Validation

Once the URS is drafted, conduct a review and validation process involving all stakeholders. This ensures that the URS reflects the collective understanding and agreement of what is required for successful implementation.

Interface Validation: Ensuring Data Integrity

Interface validation is central to ensuring that master data flows smoothly between interconnected systems. The data integrity principles of ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and Complete) should guide this process.

Step 1: Mapping Interfaces

Efficient interface validation begins with mapping all interfaces that affect master data. Document how data is transferred from one system to another. This includes:

• Data sources (e.g., ERP systems)
• Data targets (e.g., serialization software)
• Protocols governing data transfer (e.g., APIs, flat files)

Step 2: Develop Test Plans

Following the interface mapping, develop comprehensive test plans to ensure data integrity throughout the exchanges. Address aspects such as:

• Data formatting and structures
• Error handling capabilities
• Timeout and reconnection scenarios

Step 3: Execute Testing

Conduct thorough testing as specified in the test plan. Common tests include:

• Functional testing to verify all requirements are satisfied
• Performance testing to assess system responsiveness
• Security testing to protect against unauthorized data access

Step 4: Document Results and Address Issues

Document all results of the testing phase meticulously. Any issues identified should be addressed immediately, with a focus on resolving underlying causes to maintain data integrity. Accessibility of this documentation to all stakeholders is critical to maintaining transparency.

Data Governance: Standing Procedures and Change Control

Master data governance is fundamental in ensuring compliance, accuracy, and consistency across data flows in the drug manufacturing process. Establish clear procedures for data management, including:

Step 1: Establish Governance Roles

Assign governance roles that clarify responsibilities for data management. This could be in the form of a governance committee involving QA, RA, and IT representatives. Clearly delineated roles enhance accountability.

Step 2: Define Reconciliation Rules

Set forth reconciliation rules established during master data creation and modification. These rules help ensure that all instances of data across various systems are synchronized and discrepancy-free, further supporting data integrity across supply chains.

Step 3: Implement Audit Trail Review Processes

A robust audit trail review process supports compliance by capturing information regarding who accessed or altered data, when changes were made, and what the nature of those changes was. Regular audits of these trails are essential for identifying potential issues or irregularities.

Step 4: Develop Exception Handling Procedures

Exception handling should be an integral part of your governance process. Define clear procedures that delineate how exceptions are identified, managed, and resolved. This may include steps for rework and tracking resolution timelines, which are essential for compliance documentation.

Executing Change Control for Serialization

Change control is critical for managing alterations in serialization processes effectively. It prevents disruptions in the data flows and ensures compliance with regulatory standards.

Step 1: Identify Change Control Triggers

Identify potential triggers for change control, such as:

• Modifications in regulations (e.g., new DSCSA requirements)
• Technology upgrades (e.g., new serialization software)
• Changes in operational processes (e.g., new packaging equipment)

Step 2: Conduct Risk Assessments

For each potential change, perform a comprehensive risk assessment. This will help understand the impact of the change on master data flows and compliance. Consider potential risks to data integrity, supply chain disruptions, and regulatory challenges.

Step 3: Update URS and Validation Documentation

Amend the URS and other relevant validation documentation to reflect any approved changes. This process should be documented in compliance with regulatory standards to ensure traceability.

Step 4: Implement and Validate

Implement approved changes in a controlled environment, followed by a validation process that verifies their efficacy and compliance with the specifications outlined in the governance framework.

Conclusion: The Path to Master Data Flow Excellence

Master data flows are a critical component of serialization and aggregation in the pharmaceutical industry. By adhering to best practices in URS development, interface validation, data governance, and change control, pharma professionals can navigate the complexities of compliance while ensuring the integrity of their data. Continuous monitoring and enhancement of these processes will foster a resilient supply chain and uphold the patient’s trust in medicinal products.

As the landscape of pharmaceutical regulations continues to evolve, remaining vigilant to changes and continuously improving your master data governance practices is essential. Engaging all stakeholders throughout this process fosters a culture of transparency and collaboration, which ultimately benefits compliance and operational excellence.